Severe thrombocytopenia is a rare but potentially fatal outcome in patients with Zika virus infection, and treating such cases for idiopathic thrombocytopenic purpura may be more effective than platelet transfusion, a study found.
Researchers from the CDC and Puerto Rico Department of Health reviewed the medical records of patients diagnosed with Zika virus infection in 2016 in Puerto Rico, which was hit hard during the Zika epidemic.
According to Tyler M. Sharp, PhD, a U.S. Public Health Service commander and epidemiologist for the CDCs Dengue Branch, and colleagues, among 37,878 patients

Source link